January 27, 2020 / 6:12 AM / 21 days ago

Swiss stocks - Factors to watch on January 27

ZURICH/BERLIN, Jan 27 (Reuters) - The Swiss blue-chip SMI was seen opening 1.2% lower at 10,724 points on Monday, according to premarket indications by bank Julius Baer .

Here are some of the main factors that may affect Swiss stocks:


Switzerland’s market supervisor is scrutinising Credit Suisse’s oversight of chief executive Tidjane Thiam and his top lieutenants as part of a probe into corporate espionage, two people with direct knowledge of the investigation said.


The Swiss food giant on Monday bulked up its medical nutrition business by buying Allergan’s AGN.N Zenpep, a product for people whose pancreases do not provide enough enzymes to properly digest fats, proteins and sugars.

Company statements:

* Roche said it submitted an application for approval of its Tecentriq immunotherapy with Avastin for liver cancer.

* Santhera reported net revenues of 27.9 million Swiss francs ($28.84 million) for 2019, down from 31.4 million a year ago, and said it had 31.4 million francs in freely available liquid funds.

* Lastminute said, in response to an Italian newspaper article, that it is constrantly reviewing strategic opportunities, including sales, acquisitions and control of the company.

* Schmolz & Bickenbach said on Friday that Oliver Thum is resigning from the board with immediate effect.

Landis+Gyr Group confirmed full year 2019 guidance at lower end of all ranges.


No major economic data scheduled.

$1 = 0.9675 Swiss francs Reporting by Zurich newsroom and Berlin Speed Desk

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below